In Stock
Sorafenib is used to treat kidney, liver, and thyroid cancer.
It works by slowing or stopping the growth of cancer cells.
Sorafenib, sold under the brand name Nexavar, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
Origin
Made in, and imported from India
Brand
Active Substance
SorafenibUses
- Renal cell carcinoma (RCC)
- Unresectable hepatocellular carcinomas (HCC)
- Thyroid cancer